6-TERT-BUTYL 1-METHYL 6-AZASPIRO[2.5]OCTANE-1,6-DICARBOXYLATE, 95.0%, 5g

n-(2-Aminoethyl)-3-({2-[(2-aminoethyl)carbamoyl]ethyl}({2-[bis({2-[(2-aminoethyl)carbamoyl]ethyl})amino]ethyl})amino)propanamide, 98%, 5g

Quinazolin-7-ylboronic acid, 95.0%, 1g

5-(Difluoromethoxy)pyridin-2-amine, 95+%, 250mg

4-Chloropyrimidine-5-carboxylic acid, 95+%, 1g

2,5,8,11,14,17,20,23,26,29,32,35,38,41-Tetradecaoxatritetracontan-43-ol, 95%, 1g

5-Chloro-2-fluoro-N-hydroxy-benzamidine, 95.0%, 1g

1-(3-Bromo-4-methoxyphenyl)-2,2,2-trifluoroethan-1-ol, 95%, 50mg

Colonne HPLC NUCLEODUR® C8 Gravité 5 µm, 150 mm, 4 mm, 1 Pièce(s)

6-Chloro-benzo[1,3]dioxol-5-ylamine, 98%, 5g

4-oxo-6-(trifluoromethyl)-1,4-dihydropyridine-3-carboxylic acid, 98%, 500mg

Barreaux magnétiques ROTILABO® elliptique, , 20 mm, 64 mm, 1 pièce

2-tert-Butoxycarbonylaminomalonic acid monoethyl ester, 95.0%, 10g